Modular Medical, Inc. (MODD) 10-Year Financial Performance & Capital Metrics

MODD • • Industrial / General

HealthcareMedical DevicesDiabetes & Metabolic DevicesContinuous Glucose Monitoring

AboutModular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.Show more

Revenue $0
EBITDA -$18M -5.1%
Net Income -$19M -7.8%
EPS (Diluted) -0.51 +34.6%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -131.58% +37.4%
ROIC -344.61% +17.2%
Debt/Equity 0.05 -53.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Trading at only 1.0x book value

✗Weaknesses

✗Weak momentum: RS Rating 12 (bottom 12%)
✗Shares diluted 65.4% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-29.93%

EPS CAGR

10Y-

5Y-

3Y-

TTM19.05%

ROCE

10Y Avg-194.79%

5Y Avg-312.74%

3Y Avg-166.45%

Latest-127.74%

Peer Comparison

Continuous Glucose Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PODDInsulet Corporation	20.15B	286.49	49.57	22.07%	9.76%	17.79%	1.52%	1.17
DXCMDexCom, Inc.	27B	69.24	48.76	11.34%	15.96%	26.44%	2.34%	1.23
AHCOAdaptHealth Corp.	1.44B	10.64	17.44	1.9%	2.81%	4.93%	16.36%	1.35
MODDModular Medical, Inc.	36.82M	0.47	-0.93			-276.23%		0.05
SENSSenseonics Holdings, Inc.	297.04M	7.27	-2.91	0.37%	-209.21%	-82.83%
TNDMTandem Diabetes Care, Inc.	1.43B	21.07	-14.33	25.74%	-20.2%	-152.95%	0.35%	1.80

Profit & Loss

	Jun 2016	Jun 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales/Revenue+	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold+	0	0	1.86K	14.47K	35.43K	181.84K	196.92K	355.45K	768K	1.43M
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit+	0	0	-1.86K	-14.47K	-35.43K	-181.84K	-196.92K	-355.45K	-768K	-1.43M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-6.77%	-1.45%	-4.13%	-0.08%	-0.81%	-1.16%	-0.87%
Operating Expenses+	13.16K	91.05K	666.16K	2.58M	5.31M	7.15M	14.73M	13.52M	16.76M	17.61M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	13.16K	91.05K	331.66K	694.95K	2.28M	3.07M	7M	4.46M	3.88M	2.92M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-
Research & Development	0	0	332.64K	1.88M	3.03M	4.08M	7.73M	9.06M	12.88M	14.7M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-13.16K	-91.05K	-666.16K	-2.58M	-5.35M	-7.34M	-14.93M	-13.88M	-17.53M	-19.05M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.18%	-5.92%	-6.32%	-2.87%	-1.08%	-0.37%	-1.03%	0.07%	-0.26%	-0.09%
EBITDA+	0	-61.63K	-664.3K	-2.56M	-5.31M	-7.15M	-14.73M	-13.52M	-16.76M	-17.61M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-	-	-9.78%	-2.86%	-1.07%	-0.35%	-1.06%	0.08%	-0.24%	-0.05%
D&A (Non-Cash Add-back)	13.16K	29.42K	1.86K	14.47K	35.43K	181.84K	196.92K	355.45K	768K	1.43M
EBIT	-13.16K	-29.42K	-666.16K	-2.58M	-5.32M	-7.34M	-15.88M	-13.88M	-17.47M	-18.82M
Net Interest Income+	0	0	0	0	28.75K	-39.66K	-2.75M	0	0	0
Interest Income	0	0	8.52K	39.39K	28.75K	130	0	0	0	0
Interest Expense	17.92K	15.51K	0	0	0	39.79K	2.75M	0	0	0
Other Income/Expense	-17.92K	62.59K	8.52K	39.39K	28.75K	-39.66K	-3.7M	975	61K	226K
Pretax Income+	-31.08K	-106.56K	-657.65K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	0	800	1.6K	1.59K	1.6K	1.6K	1.6K	1.6K	2K	2K
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-31.08K	-106.56K	-659.25K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0%	-2.43%	-5.19%	-2.85%	-1.1%	-0.39%	-1.53%	0.26%	-0.26%	-0.08%
Net Income (Continuing)	-31.08K	-29.26K	-659.25K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.07	-0.09	-0.15	-0.46	-0.89	-1.19	-2.74	-1.28	-0.78	-0.51
EPS Growth %	-0%	-0.22%	-0.64%	-2.07%	-0.93%	-0.34%	-1.3%	0.53%	0.39%	0.35%
EPS (Basic)	-0.07	-0.09	-0.15	-0.46	-0.89	-1.19	-2.74	-1.28	-0.78	-0.51
Diluted Shares Outstanding	416.6K	1.17M	4.45M	5.53M	5.95M	6.21M	6.81M	10.88M	22.38M	37.01M
Basic Shares Outstanding	416.6K	1.17M	4.45M	5.53M	5.95M	6.21M	6.81M	10.88M	22.38M	37.01M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Jun 2016	Jun 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Current Assets+	0	1.37M	4.31M	6.57M	3.19M	1.65M	9.39M	4.05M	9.7M	13.52M
Cash & Short-Term Investments	0	1.37M	4.3M	6.55M	3.12M	1.47M	9.08M	3.8M	9.23M	13.1M
Cash Only	0	1.37M	4.3M	6.55M	3.12M	1.47M	9.08M	3.8M	9.23M	13.1M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	0	0	0	0	0	0	0	5K	147K	70K
Days Sales Outstanding	-	-	-	-	-	-	-	-	-	-
Inventory	0	0	0	0	0	0	0	95K	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	97.55	-	-
Other Current Assets	0	0	16.8K	0	306	2.47K	0	0	0	0
Total Non-Current Assets+	0	0	20.97K	83.63K	672.26K	599.08K	456.65K	3.2M	4.11M	5.22M
Property, Plant & Equipment	0	0	13.26K	75.95K	572.26K	499.08K	356.65K	3.2M	4.11M	5.22M
Fixed Asset Turnover	-	-	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	213	180	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	7.5K	7.5K	100K	100K	100K	0	0	0
Total Assets+	0	1.37M	4.33M	6.65M	3.86M	2.25M	9.85M	7.25M	13.81M	18.73M
Asset Turnover	-	-	-	-	-	-	-	-	-	-
Asset Growth %	-1%	-	2.16%	0.53%	-0.42%	-0.42%	3.38%	-0.26%	0.91%	0.36%
Total Current Liabilities+	193.76K	74.42K	15.47K	178.93K	661.39K	3.3M	969.7K	979K	1.46M	1.26M
Accounts Payable	0	0	0	138.31K	367.02K	169.28K	299.95K	285K	802K	338K
Days Payables Outstanding	-	-	-	3.49K	3.78K	339.8	555.97	292.66	381.16	86.09
Short-Term Debt	0	0	0	0	0	2.5M	0	0	0	0
Deferred Revenue (Current)	0	0	-516	0	0	0	0	0	0	0
Other Current Liabilities	0	0	516	0	0	0	0	0	0	0
Current Ratio	-	18.44x	278.81x	36.71x	4.82x	0.50x	9.68x	4.13x	6.66x	10.69x
Quick Ratio	-	18.44x	278.81x	36.71x	4.82x	0.50x	9.68x	4.04x	6.66x	10.69x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	0	0	0	0	318.74K	226.35K	39.96K	1.19M	817K	393K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	178.74K	184.35K	39.96K	1.19M	817K	393K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	140K	42K	0	-33	0	0
Total Liabilities	193.76K	74.42K	15.47K	178.93K	980.13K	3.52M	1.01M	2.17M	2.27M	1.66M
Total Debt+	131.09K	21.26K	516	0	270.95K	2.81M	184.81K	1.55M	1.19M	816K
Net Debt	131.09K	-1.35M	-4.3M	-6.55M	-2.85M	1.34M	-8.89M	-2.25M	-8.04M	-12.28M
Debt / Equity	-	0.02x	0.00x	-	0.09x	-	0.02x	0.30x	0.10x	0.05x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-0.73x	-5.87x	-	-	-	-184.38x	-5.42x	-	-	-
Total Equity+	-193.76K	1.3M	4.32M	6.47M	2.88M	-1.28M	8.84M	5.08M	11.54M	17.08M
Equity Growth %	-0.19%	7.7%	2.33%	0.5%	-0.56%	-1.44%	7.93%	-0.43%	1.27%	0.48%
Book Value per Share	-0.47	1.11	0.97	1.17	0.48	-0.21	1.30	0.47	0.52	0.46
Total Shareholders' Equity	-193.76K	1.3M	4.32M	6.47M	2.88M	-1.28M	8.84M	5.08M	11.54M	17.08M
Common Stock	1.25K	3.5K	15.98K	17.84K	17.87K	6.3K	10.46K	10.95K	32K	54K
Retained Earnings	-277.84K	-384.4K	-708.66K	-3.25M	-8.57M	-15.95M	-34.58M	-48.46M	-65.93M	-84.75M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	19.8K	923.99K	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Jun 2016	Jun 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operations+	-10.66K	-94.81K	-791.13K	-1.81M	-4.09M	-5.91M	-10.26M	-11.01M	-13.95M	-15.72M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-	-7.89%	-7.34%	-1.29%	-1.26%	-0.44%	-0.74%	-0.07%	-0.27%	-0.13%
Net Income	-31.08K	-106.56K	-659.25K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Depreciation & Amortization	0	0	1.86K	14.47K	35.43K	181.84K	117.49K	152.4K	768K	1.06M
Stock-Based Compensation	0	0	0	532.11K	801.24K	1.23M	4.03M	2.72M	2.7M	2.38M
Deferred Taxes	0	0	0	0	-341.86K	0	0	0	0	0
Other Non-Cash Items	0	-3	3.72K	19.8K	341.86K	121.04K	3.85M	202.67K	143K	52K
Working Capital Changes	20.42K	11.75K	-133.75K	165.19K	389.36K	-61.15K	374.99K	-211.82K	-94K	-392K
Change in Receivables	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	-109.75K	0	530.25K	0	0	-200.76K	458K	0
Cash from Investing+	0	0	-15.33K	-77.12K	-260.79K	-109.67K	-54.76K	-1.64M	-1.7M	-2.49M
Capital Expenditures	0	0	-15.33K	-77.12K	-260.79K	-109.67K	-54.76K	-1.64M	-1.7M	-2.49M
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-213	0	0	0	0	0	0	0
Cash from Financing+	10.66K	1.47M	4.71M	4.14M	923.99K	4.36M	17.92M	7.37M	21.09M	22.08M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	10.66K	1.48M	-20.74K	-516	0	0	0	-347	742K	1.25M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-10.66K	-94.81K	-806.46K	-1.89M	-4.36M	-6.02M	-10.31M	-12.65M	-15.65M	-18.21M
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-	-7.89%	-7.51%	-1.34%	-1.31%	-0.38%	-0.71%	-0.23%	-0.24%	-0.16%
FCF per Share	-0.03	-0.08	-0.18	-0.34	-0.73	-0.97	-1.52	-1.16	-0.70	-0.49
FCF Conversion (FCF/Net Income)	0.34x	0.89x	1.20x	0.71x	0.77x	0.80x	0.55x	0.79x	0.80x	0.84x
Interest Paid	0	0	0	0	0	0	262K	0	0	0
Taxes Paid	0	0	1.6K	1.59K	1.6K	1.6K	1.6K	2K	2K	2K

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-	-19.3%	-23.47%	-47.06%	-113.79%	-920.36%	-492.82%	-199.51%	-210.34%	-131.58%
Return on Invested Capital (ROIC)	-	-	-2189.31%	-	-14725.81%	-11498.11%	-163356.22%	-752.33%	-416.38%	-344.61%
Debt / Equity	-	0.02x	0.00x	-	0.09x	-	0.02x	0.30x	0.10x	0.05x
Interest Coverage	-0.73x	-5.87x	-	-	-	-184.38x	-5.42x	-	-	-
FCF Conversion	0.34x	0.89x	1.20x	0.71x	0.77x	0.80x	0.55x	0.79x	0.80x	0.84x

Frequently Asked Questions

Growth & Financials

Modular Medical, Inc. (MODD) grew revenue by 0.0% over the past year. Growth has been modest.

Modular Medical, Inc. (MODD) reported a net loss of $24.2M for fiscal year 2025.

Dividend & Returns

Modular Medical, Inc. (MODD) has a return on equity (ROE) of -131.6%. Negative ROE indicates the company is unprofitable.

Modular Medical, Inc. (MODD) had negative free cash flow of $22.4M in fiscal year 2025, likely due to heavy capital investments.

← Back to Screener

US Stock Screener

...

Modular Medical, Inc. (MODD) 10-Year Financial Performance & Capital Metrics

MODD • • Industrial / General

HealthcareMedical DevicesDiabetes & Metabolic DevicesContinuous Glucose Monitoring

Revenue $0
EBITDA -$18M -5.1%
Net Income -$19M -7.8%
EPS (Diluted) -0.51 +34.6%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -131.58% +37.4%
ROIC -344.61% +17.2%
Debt/Equity 0.05 -53.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Trading at only 1.0x book value

✗Weaknesses

✗Weak momentum: RS Rating 12 (bottom 12%)
✗Shares diluted 65.4% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-29.93%

EPS CAGR

10Y-

5Y-

3Y-

TTM19.05%

ROCE

10Y Avg-194.79%

5Y Avg-312.74%

3Y Avg-166.45%

Latest-127.74%

Peer Comparison

Continuous Glucose Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PODDInsulet Corporation	20.15B	286.49	49.57	22.07%	9.76%	17.79%	1.52%	1.17
DXCMDexCom, Inc.	27B	69.24	48.76	11.34%	15.96%	26.44%	2.34%	1.23
AHCOAdaptHealth Corp.	1.44B	10.64	17.44	1.9%	2.81%	4.93%	16.36%	1.35
MODDModular Medical, Inc.	36.82M	0.47	-0.93			-276.23%		0.05
SENSSenseonics Holdings, Inc.	297.04M	7.27	-2.91	0.37%	-209.21%	-82.83%
TNDMTandem Diabetes Care, Inc.	1.43B	21.07	-14.33	25.74%	-20.2%	-152.95%	0.35%	1.80

Profit & Loss

	Jun 2016	Jun 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales/Revenue+	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold+	0	0	1.86K	14.47K	35.43K	181.84K	196.92K	355.45K	768K	1.43M
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit+	0	0	-1.86K	-14.47K	-35.43K	-181.84K	-196.92K	-355.45K	-768K	-1.43M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-6.77%	-1.45%	-4.13%	-0.08%	-0.81%	-1.16%	-0.87%
Operating Expenses+	13.16K	91.05K	666.16K	2.58M	5.31M	7.15M	14.73M	13.52M	16.76M	17.61M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	13.16K	91.05K	331.66K	694.95K	2.28M	3.07M	7M	4.46M	3.88M	2.92M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-
Research & Development	0	0	332.64K	1.88M	3.03M	4.08M	7.73M	9.06M	12.88M	14.7M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-13.16K	-91.05K	-666.16K	-2.58M	-5.35M	-7.34M	-14.93M	-13.88M	-17.53M	-19.05M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.18%	-5.92%	-6.32%	-2.87%	-1.08%	-0.37%	-1.03%	0.07%	-0.26%	-0.09%
EBITDA+	0	-61.63K	-664.3K	-2.56M	-5.31M	-7.15M	-14.73M	-13.52M	-16.76M	-17.61M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-	-	-9.78%	-2.86%	-1.07%	-0.35%	-1.06%	0.08%	-0.24%	-0.05%
D&A (Non-Cash Add-back)	13.16K	29.42K	1.86K	14.47K	35.43K	181.84K	196.92K	355.45K	768K	1.43M
EBIT	-13.16K	-29.42K	-666.16K	-2.58M	-5.32M	-7.34M	-15.88M	-13.88M	-17.47M	-18.82M
Net Interest Income+	0	0	0	0	28.75K	-39.66K	-2.75M	0	0	0
Interest Income	0	0	8.52K	39.39K	28.75K	130	0	0	0	0
Interest Expense	17.92K	15.51K	0	0	0	39.79K	2.75M	0	0	0
Other Income/Expense	-17.92K	62.59K	8.52K	39.39K	28.75K	-39.66K	-3.7M	975	61K	226K
Pretax Income+	-31.08K	-106.56K	-657.65K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	0	800	1.6K	1.59K	1.6K	1.6K	1.6K	1.6K	2K	2K
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-31.08K	-106.56K	-659.25K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0%	-2.43%	-5.19%	-2.85%	-1.1%	-0.39%	-1.53%	0.26%	-0.26%	-0.08%
Net Income (Continuing)	-31.08K	-29.26K	-659.25K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.07	-0.09	-0.15	-0.46	-0.89	-1.19	-2.74	-1.28	-0.78	-0.51
EPS Growth %	-0%	-0.22%	-0.64%	-2.07%	-0.93%	-0.34%	-1.3%	0.53%	0.39%	0.35%
EPS (Basic)	-0.07	-0.09	-0.15	-0.46	-0.89	-1.19	-2.74	-1.28	-0.78	-0.51
Diluted Shares Outstanding	416.6K	1.17M	4.45M	5.53M	5.95M	6.21M	6.81M	10.88M	22.38M	37.01M
Basic Shares Outstanding	416.6K	1.17M	4.45M	5.53M	5.95M	6.21M	6.81M	10.88M	22.38M	37.01M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Jun 2016	Jun 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Current Assets+	0	1.37M	4.31M	6.57M	3.19M	1.65M	9.39M	4.05M	9.7M	13.52M
Cash & Short-Term Investments	0	1.37M	4.3M	6.55M	3.12M	1.47M	9.08M	3.8M	9.23M	13.1M
Cash Only	0	1.37M	4.3M	6.55M	3.12M	1.47M	9.08M	3.8M	9.23M	13.1M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	0	0	0	0	0	0	0	5K	147K	70K
Days Sales Outstanding	-	-	-	-	-	-	-	-	-	-
Inventory	0	0	0	0	0	0	0	95K	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	97.55	-	-
Other Current Assets	0	0	16.8K	0	306	2.47K	0	0	0	0
Total Non-Current Assets+	0	0	20.97K	83.63K	672.26K	599.08K	456.65K	3.2M	4.11M	5.22M
Property, Plant & Equipment	0	0	13.26K	75.95K	572.26K	499.08K	356.65K	3.2M	4.11M	5.22M
Fixed Asset Turnover	-	-	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	213	180	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	7.5K	7.5K	100K	100K	100K	0	0	0
Total Assets+	0	1.37M	4.33M	6.65M	3.86M	2.25M	9.85M	7.25M	13.81M	18.73M
Asset Turnover	-	-	-	-	-	-	-	-	-	-
Asset Growth %	-1%	-	2.16%	0.53%	-0.42%	-0.42%	3.38%	-0.26%	0.91%	0.36%
Total Current Liabilities+	193.76K	74.42K	15.47K	178.93K	661.39K	3.3M	969.7K	979K	1.46M	1.26M
Accounts Payable	0	0	0	138.31K	367.02K	169.28K	299.95K	285K	802K	338K
Days Payables Outstanding	-	-	-	3.49K	3.78K	339.8	555.97	292.66	381.16	86.09
Short-Term Debt	0	0	0	0	0	2.5M	0	0	0	0
Deferred Revenue (Current)	0	0	-516	0	0	0	0	0	0	0
Other Current Liabilities	0	0	516	0	0	0	0	0	0	0
Current Ratio	-	18.44x	278.81x	36.71x	4.82x	0.50x	9.68x	4.13x	6.66x	10.69x
Quick Ratio	-	18.44x	278.81x	36.71x	4.82x	0.50x	9.68x	4.04x	6.66x	10.69x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	0	0	0	0	318.74K	226.35K	39.96K	1.19M	817K	393K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	178.74K	184.35K	39.96K	1.19M	817K	393K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	140K	42K	0	-33	0	0
Total Liabilities	193.76K	74.42K	15.47K	178.93K	980.13K	3.52M	1.01M	2.17M	2.27M	1.66M
Total Debt+	131.09K	21.26K	516	0	270.95K	2.81M	184.81K	1.55M	1.19M	816K
Net Debt	131.09K	-1.35M	-4.3M	-6.55M	-2.85M	1.34M	-8.89M	-2.25M	-8.04M	-12.28M
Debt / Equity	-	0.02x	0.00x	-	0.09x	-	0.02x	0.30x	0.10x	0.05x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-0.73x	-5.87x	-	-	-	-184.38x	-5.42x	-	-	-
Total Equity+	-193.76K	1.3M	4.32M	6.47M	2.88M	-1.28M	8.84M	5.08M	11.54M	17.08M
Equity Growth %	-0.19%	7.7%	2.33%	0.5%	-0.56%	-1.44%	7.93%	-0.43%	1.27%	0.48%
Book Value per Share	-0.47	1.11	0.97	1.17	0.48	-0.21	1.30	0.47	0.52	0.46
Total Shareholders' Equity	-193.76K	1.3M	4.32M	6.47M	2.88M	-1.28M	8.84M	5.08M	11.54M	17.08M
Common Stock	1.25K	3.5K	15.98K	17.84K	17.87K	6.3K	10.46K	10.95K	32K	54K
Retained Earnings	-277.84K	-384.4K	-708.66K	-3.25M	-8.57M	-15.95M	-34.58M	-48.46M	-65.93M	-84.75M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	19.8K	923.99K	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Jun 2016	Jun 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operations+	-10.66K	-94.81K	-791.13K	-1.81M	-4.09M	-5.91M	-10.26M	-11.01M	-13.95M	-15.72M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-	-7.89%	-7.34%	-1.29%	-1.26%	-0.44%	-0.74%	-0.07%	-0.27%	-0.13%
Net Income	-31.08K	-106.56K	-659.25K	-2.54M	-5.32M	-7.38M	-18.63M	-13.88M	-17.47M	-18.82M
Depreciation & Amortization	0	0	1.86K	14.47K	35.43K	181.84K	117.49K	152.4K	768K	1.06M
Stock-Based Compensation	0	0	0	532.11K	801.24K	1.23M	4.03M	2.72M	2.7M	2.38M
Deferred Taxes	0	0	0	0	-341.86K	0	0	0	0	0
Other Non-Cash Items	0	-3	3.72K	19.8K	341.86K	121.04K	3.85M	202.67K	143K	52K
Working Capital Changes	20.42K	11.75K	-133.75K	165.19K	389.36K	-61.15K	374.99K	-211.82K	-94K	-392K
Change in Receivables	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	-109.75K	0	530.25K	0	0	-200.76K	458K	0
Cash from Investing+	0	0	-15.33K	-77.12K	-260.79K	-109.67K	-54.76K	-1.64M	-1.7M	-2.49M
Capital Expenditures	0	0	-15.33K	-77.12K	-260.79K	-109.67K	-54.76K	-1.64M	-1.7M	-2.49M
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-213	0	0	0	0	0	0	0
Cash from Financing+	10.66K	1.47M	4.71M	4.14M	923.99K	4.36M	17.92M	7.37M	21.09M	22.08M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	10.66K	1.48M	-20.74K	-516	0	0	0	-347	742K	1.25M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-10.66K	-94.81K	-806.46K	-1.89M	-4.36M	-6.02M	-10.31M	-12.65M	-15.65M	-18.21M
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-	-7.89%	-7.51%	-1.34%	-1.31%	-0.38%	-0.71%	-0.23%	-0.24%	-0.16%
FCF per Share	-0.03	-0.08	-0.18	-0.34	-0.73	-0.97	-1.52	-1.16	-0.70	-0.49
FCF Conversion (FCF/Net Income)	0.34x	0.89x	1.20x	0.71x	0.77x	0.80x	0.55x	0.79x	0.80x	0.84x
Interest Paid	0	0	0	0	0	0	262K	0	0	0
Taxes Paid	0	0	1.6K	1.59K	1.6K	1.6K	1.6K	2K	2K	2K

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-	-19.3%	-23.47%	-47.06%	-113.79%	-920.36%	-492.82%	-199.51%	-210.34%	-131.58%
Return on Invested Capital (ROIC)	-	-	-2189.31%	-	-14725.81%	-11498.11%	-163356.22%	-752.33%	-416.38%	-344.61%
Debt / Equity	-	0.02x	0.00x	-	0.09x	-	0.02x	0.30x	0.10x	0.05x
Interest Coverage	-0.73x	-5.87x	-	-	-	-184.38x	-5.42x	-	-	-
FCF Conversion	0.34x	0.89x	1.20x	0.71x	0.77x	0.80x	0.55x	0.79x	0.80x	0.84x

Frequently Asked Questions

Growth & Financials

Modular Medical, Inc. (MODD) grew revenue by 0.0% over the past year. Growth has been modest.

Modular Medical, Inc. (MODD) reported a net loss of $24.2M for fiscal year 2025.

Dividend & Returns

Modular Medical, Inc. (MODD) has a return on equity (ROE) of -131.6%. Negative ROE indicates the company is unprofitable.

Modular Medical, Inc. (MODD) had negative free cash flow of $22.4M in fiscal year 2025, likely due to heavy capital investments.